|
Match
|
Document |
Document Title |
|
|
US20090292026 |
Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is disclosed....
|
|
|
US20090281187 |
ANTI-ALLERGIC AGENT
The inventors have found that vitamin K3 and vitamin K5 which may be used in pharmaceuticals and foods or ACNQ, DHNA, or the like which can stimulate the growth of bifidobacteria can inhibit...
|
|
|
US20090258949 |
AMORPHOUS FORM OF CINACALCET
The present invention relates to dispersions of stable amorphous cinacalcet hydrochloride in a matrix material, methods for the preparation thereof, and pharmaceutical compositions comprising said...
|
|
|
US20090247537 |
METHODS FOR PREVENTING OR TREATING BRUXISM USING DOPAMINERGIC AGENTS
Methods for preventing or treating bruxism, including alleviating or eliminating one or more symptoms, diseases or conditions associated with or resulting from bruxism, using dopaminergic agents...
|
|
|
US20090215852 |
COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA
The invention provides preparations, formulations, kits and other products of manufacture (e.g., blister packs) comprising combinations of beneficial ingredients that are serviceable as therapies...
|
|
|
US20090203750 |
5-HT2C Receptor Agonists as Anorectic Agents
This invention relates to compounds which modulate receptors of the 5-HT2 family of receptors, and particularly to compounds which modulate 5-HT2C receptors. Compounds of the invention include...
|
|
|
US20090182057 |
DEUTERATED AMINOGLYCIDAL COMPOUNDS
Provided herein are substituted aminoglycidyl compounds of Formula (1), processes of preparation, and pharmaceutical compositions thereof and methods of their use for treating, preventing, or...
|
|
|
US20090149549 |
PREPARATION OF CHIRAL AMIDES AND AMINES
This invention provides a convenient method for converting oximes into enamides. The process does not require the use of metallic reagents. Accordingly, it produces the desired compounds without...
|
|
|
US20090136549 |
TRANSDERMAL PATCH CONTAINING RASAGILINE FOR TREATMENT OR PROPHYLAXIS OF NERVOUS SYSTEM DISEASE AND ITS PREPARATION PROCESS
The present invention relates to a rasagiline transdermal patch for treatment or prophylaxis of nervous system diseases, in which the patch comprises an inert backing layer chemically inert to...
|
|
|
US20090131535 |
PROPARGYLAMINO INDAN DERIVATIVES AND PROPARGYLAMINO TETRALIN DERIVATIVES AS BRAIN-SELECTIVE MAO INHIBITORS
The subject invention provides derivatives of propargylamino indan (PAI) and propargylamino tetralin that selectively inhibit monoamine oxidase (MAO) in the brain, having the structure:
wherein...
|
|
|
US20090111892 |
Rasagiline Orally Disintegrating Compositions
This invention provides a solid pharmaceutical composition comprising rasagiline or a pharmaceutically acceptable salt of rasagiline, and particles having a non-filamentous microstructure of at...
|
|
|
US20090062400 |
Method of treating glaucoma using rasagiline
Disclosed is a method of reducing glaucoma in a subject afflicted with glaucoma, comprising administering to the subject an amount of R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptably...
|
|
|
US20090062399 |
DEUTERIUM-ENRICHED SERTRALINE
The present application describes deuterium-enriched sertraline, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
|
|
|
US20080306163 |
AGENT FOR TREATMENT OF ALLERGIC EYE DISEASE
An agent for the treatment of allergic eye disease containing a 3-anilino-2-cycloalkenone derivative having the formula (I):
wherein R 1 is an unsubstituted or substituted C 1 to C 8 alkyl...
|
|
|
US20080306031 |
Methods of Inhibiting Poxvirus Growth
This disclosure ascribes new functions to derivatives of tetralin, anthraquinone, naphthylamine, tri-amino-pyrimidine, xanthen-3-one, and/or cinnamic acid (including, for example, NSC270718R,...
|
|
|
US20080300274 |
Novel Pyrrolidino-1,4-Naphthoquinone Deriviatives and their Use for Treating Malignancies and Cardiovascular Diseases
The invention provides pyrrolidino-substituted 1,4-naphthoquinone derivatives that modulate the activity of protein kinases, and it relates to the use of the derivatives in pharmaceutical...
|
|
|
US20080255232 |
Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation
Compounds useful in the treatment of disorders characterized by deposits of amyloid aggregates are herein described together with pharmaceutical compounds containing the same. In particular the...
|
|
|
US20080249088 |
Topical Delivery of Antifungal Drugs
A topical formula for treatment of antifungal infections of the skin and nails comprises: (a) a therapeutically effective amount of a benzylamine or morpholine antifungal compound; (b) an aliphatic...
|
|
|
US20080207584 |
Compound Having S1P Receptor Binding Potency and Use Thereof
Provided are: a compound represented by formula (I):
(wherein ring A and ring D each represent a cyclic group which may have a substituent(s); E and G each represent a bond or a spacer having 1...
|
|
|
US20080200458 |
Methods and compositions for the treatment of body composition disorders
This invention relates to methods of treating, managing and preventing body composition disorders, and to compounds and pharmaceutical compositions useful in such methods.
|
|
|
US20080194696 |
Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
The invention provides novel arylbicyclo[3.1.0]hexylamines, and related processes and intermediates for preparing these compounds, as well as compositions and methods employing these compounds for...
|
|
|
US20080161412 |
Process for preparation of sertraline hydrochloride form I
Provided is a process for preparation of sertraline HCl Form I on an industrial scale.
|
|
|
US20080160009 |
Inhibiting Cav3 Isoforms and the 25B Splice Varients for the Diagnosis and Treatment of Cancer
The invention provides a pharmaceutical composition comprising an antibody that specifically binds to a Cav3 isoform or its δ25 splice variants thereof. The present invention also relates to...
|
|
|
US20080146676 |
Tannate salt of rasagiline
The subject invention provides rasagiline tannate, compositions and a process for manufacture thereof.
|
|
|
US20080146622 |
Use Of Substituted 2-Aminotetralins For Preventive Treatment Of Parkinson's Disease
The invention relates to the use of substituted 2-aminotetralins of general formula (I)
as a medicament for the preventive treatment of Parkinson's disease.
|
|
|
US20080114071 |
Processes for preparing sertraline
Provided are processes for the preparation of sertraline and sertraline hydrochloride.
|
|
|
US20080033052 |
Dermal anesthetic compounds
The present invention relates to new tetralin compounds, the methods of preparing said tetralin compounds, the method of using said tetralin compounds as local anesthetics and dermal anesthetics,...
|
|
|
US20080021016 |
Combined Pharmaceutical Composition for the Inhibition of the Decline of Cognitive Functions
The invention relates to a combined pharmaceutical composition for the inhibition of the decline of cognitive functions comprising as A) component...
|
|
|
US20080003275 |
Treatment of Premature Ejaculation
The invention relates to methods and compositions for treating premature ejaculation in a male or prolonging intercourse comprising administering to the male an antidepressant via a route selected...
|